Journal Information
Vol. 44. Issue 3.
Pages 127-134 (January 2008)
Share
Share
Download PDF
More article options
Vol. 44. Issue 3.
Pages 127-134 (January 2008)
Original Articles
Full text access
Impact of Baseline and Induced Dyspnea on the Quality of Life of Patients With COPD
Visits
5053
Manuela E. Martínez Francésa, Miguel Perpiñá Torderaa, Amparo Belloch Fusterb, Eva M. Martínez Moragónc,
Corresponding author
martinez_manfra@gva.es

Correspondence: Dra M.E. Martínez Francés Servicio de Neumología, Hospital Universitario La Fe Avda. Campanar, 2146009 Valencia, Spain
, Luis Compte Torreroa
a Servicio de Neumología, Hospital Universitario La Fe, Valencia, Spain
b Departamento de Personalidad, Universidad de Valencia, Valencia, Spain
c Servicio de Medicina Interna, Hospital Comarcal de Sagunto, Sagunto, Valencia, Spain
This item has received
Article information
Abstract
Bibliography
Download PDF
Statistics
Objective

Dyspnea is the main symptom of chronic obstructive pulmonary disease (COPD) and as such is an important determinant of health-related quality of life. It is, however, weakly correlated to severity of obstruction and there is little information available on how it exercises its effect on health-related quality of life. The aims of this study were to identify the determinants of baseline dyspnea and to ascertain how that factor influences the health-related quality of life of patients with COPD.

Patients and methods

A total of 101 patients with COPD were studied. Tests included full lung function assessment, the bronchial provocation test (n=70), and the 6-minute walk test. The following variables were measured: baseline dyspnea, bronchoconstriction-induced dyspnea, exertional dyspnea, health-related quality of life, and levels of anxiety and depression.

Results

Determinants of baseline dyspnea were anxiety (explained variance, 17%), maximum inspiratory pressure (4%), and PaO2 (4%). In patients with mild to moderate COPD (forced expiratory volume in 1 second, >50% of predicted), the main determinant of health-related quality of life was anxiety (explained variance, 43%). Other determinants were the number of meters walked in the 6-minute-walk test, age, and baseline dyspnea (variance explained by both factors, 26%). Baseline dyspnea and bronchoconstriction-induced dyspnea were both identified as independent determinants of health-related quality of life (on the activity and impact subscales of the St George's Respiratory Questionnaire, respectively). The main determinant of health-related quality of life in patients with severe COPD (forced expiratory volume in 1 second, >50% of predicted) was baseline dyspnea. Finally, the main determinants of anxiety were exertional dyspnea (variance, 42%) and baseline dyspnea (6%).

Conclusions

Anxiety is the main determinant of health-related quality of life in patients with COPD, and it is triggered mainly by baseline dyspnea and exertional dyspnea.

Key words:
Chronic obstructive pulmonary disease
COPD
Dyspnea
Health-related quality of life
Objetivo

La disnea es el principal síntoma de la enfermedad pulmonar obstructiva crónica (EPOC), por lo que tiene un papel importante en la calidad de vida relacionada con la salud (CVRS). Sin embargo, guarda una relación débil con la gravedad de la obstrucción y hay pocos datos sobre cómo influye en la CVRS. Así pues, nuestro objetivo ha sido averiguar los determinantes de la disnea basal y cómo influye ésta en la CVRS de los pacientes con EPOC.

Pacientes y métodos

Se estudió a 101 pacientes con EPOC, a los que se realizaron exploración funcional completa, test de provocación bronquial (n = 70) y test de la marcha (TM). Se midieron la disnea basal, la inducida por broncoconstrictor y por esfuerzo, la CVRS y los grados de ansiedad y depresión.

Resultados

La disnea basal vino determinada por la ansiedad (un 17% de la variancia explicada), la presión inspiratoria máxima (4%) y la presión arterial de oxígeno (4%). En la EPOC leve-moderada (volumen espiratorio forzado en el primer segundo > 50%) la CVRS se explicó fundamentalmente por la ansiedad (el 43% de la variancia). Los metros caminados en el TM, la edad y la disnea basal explicaron otro 26%. La disnea basal también apareció como determinante independiente de la CVRS en la subescala de Actividades, y la inducida por broncoconstricción en la subescala de Impacto. En la EPOC grave (volumen espiratorio forzado en el primer segundo >50%) la disnea basal fue el determinante fundamental de la CVRS. Los principales determinantes de la ansiedad fueron la disnea provocada por el TM (el 42% de la variancia) y la basal (6%).

Conclusiones

La ansiedad es el determinante fundamental de la CVRS en la EPOC; dicha ansiedad está mediada fundamentalmente por la disnea inducida por esfuerzo y la disnea basal.

Palabras clave:
EPOC
Disnea
Calidad de vida relacionada con la salud
Full text is only aviable in PDF
References
[1]
PW Jones.
Dyspnea and quality of life in chronic obstructive pulmonary disease.
Dyspnea, pp. 199-220
[2]
T Hajiro, K Nishimura, M Tsukino, et al.
A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD.
Chest, 116 (1999), pp. 1632-1637
[3]
NM Siakafas, S Schiza, N Xirouhaki, D Bouros.
Is dyspnea the main determinant of quality of life in the failing lung? A review.
Eur Respi Rev, 7 (1997), pp. 53-56
[4]
K Nishimura, T Izumi, M Tsukino, T Oga.
Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD.
Chest, 121 (2002), pp. 1434-1440
[5]
BR Celli, CG Cote, JM Marín, C Casanova, M Montes de Oca, RA Méndez, et al.
The body mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease.
N Engl J Med, 350 (2004), pp. 1005-1012
[6]
AR Rubinfield, MCF Pain.
Perception of asthma.
Lancet, 1 (1976), pp. 882-884
[7]
PJ Barnes.
Poorly perceived asthma.
Thorax, 47 (1992), pp. 408-409
[8]
Y Kiruchi, S Okabe, G Tamura, W Hida, M Homma, K Shirato, et al.
Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma.
N Engl J Med, 330 (1994), pp. 1329-1334
[9]
Statement ATS.
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 152 (1995), pp. 77S-120S
[10]
SM Brooks.
Surveillance for respiratory hazards.
ATS News, 8 (1982), pp. 12-16
[11]
GVA Borg.
Psychophysical basis of perceived exertion.
Med Sci Sports Exerc, 14 (1982), pp. 377-381
[12]
PH Quanjer, GJ Tammeling, JE Cotes, OF Pedersen, R Peslin, JC Yernault.
Lung volumes and forced ventilatory flows. Official statement of the European Respiratory Society.
Eur Respir J, 6 (1993), pp. 5-40
[13]
R Rodríguez-Roisin, A Agustí García-Navarro, F Burgos Rincón, P Casan Clará, M Perpiñá Tordera, L Sánchez Agudo, et al.
Gasometría arterial. Recomendaciones SEPAR, pp. 55-77
[14]
LF Black, RE Hyatt.
Maximal respiratory pressures: normal values and relationship to age and sex.
Am Rev Respir Dis, 99 (1969), pp. 696-702
[15]
DW Cockroft, DN Killian, JA Mellon, FE Hargreave.
Bronchial reactivity to inhaled histamine: a method and clinical survey.
Clin Allergy Immunol, 7 (1977), pp. 235-243
[16]
PJ Sterk, LM Fabbri, PH Quanjer, QW Cockroft, PM O'Byrne, SD Anderson, et al.
Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults.
Eur Respir J Suppl, 16 (1993), pp. 53-83
[17]
LP Boulet, P Leblanc, H Turcotte.
Perception scoring of induced bronchoconstriction as an index of awareness of asthma symptoms.
Chest, 105 (1994), pp. 1430-1433
[18]
ME Martínez Francés, M Perpiñá Tordera, A Belloch Fuster, EM Martínez Moragón, A De Diego Damiá.
¿Cómo valorar la percepción de la disnea inducida en la EPOC?.
Arch Bronconeumol, 40 (2004), pp. 149-154
[19]
M Ferrer, J Alonso, L Prieto, V Plaza, E Monsó, R Marrades, et al.
Validity and reliability of the St. George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example.
Eur Respir J, 9 (1996), pp. 1160-1166
[20]
N Seisdedos.
Cuestionario de Ansiedad Estado-Rasgo. Adaptación española, TEA Ediciones, (1988),
[21]
C Vázquez, J Sanz.
Fiabilidad y valores normativos de la versión española del inventario para la depresión de Beck de 1978.
Clínica y Salud, 8 (1997), pp. 403-422
[22]
NM Siakafas, P Vermeire, NB Pride, P Paoletti, J Gibson, P Howard, et al.
Optimal assessment and management of chronic obstructive pulmonary disease (COPD).
Eur Respir J, 8 (1995), pp. 1398-1420
[23]
PW Jones, CM Baveystock, P Littlejohns.
Relationships between general health status measured with the Sickness Impact Profile and respiratory symptoms, psychological measures and mood in patients with chronic airflow limitation.
Am Rev Respir Dis, 140 (1989), pp. 1538-1543
[24]
B Burrows, CM Fletcher, BE Heard, NL Jones, JS Wootlift.
The emphysematous and bronchial types of chronic airways obstruction.
Lancet, 1 (1966), pp. 830
[25]
JC Bestall, EA Paul, R Garrod, R Granham, PW Jones, JA Wedzicha.
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.
Thorax, 54 (1999), pp. 581-586
[26]
DA Mahler, A Harver.
A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease.
Am Rev Respir Dis, 145 (1992), pp. 467-470
[27]
E Martínez Moragón, M Perpiñá, A Belloch, A De Diego, ME Martínez Francés.
Percepción de la disnea durante la broncoconstricción aguda en los pacientes con asma.
Arch Bronconeumol, 39 (2003), pp. 67-73
[28]
PW Jones, FH Quirk, CM Baveystock.
The St. George's Respiratory Questionnaire.
Respir Med, 85 (1991), pp. 25-31
[29]
T Hajiro, K Nishimura, M Tsukino, A Ikeda, T Oga.
Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease.
Respir Med, 94 (2000), pp. 841-846
[30]
DE O'Donnell.
Breathlessness in patients with severe chronic airflow limitation. Mechanisms and management.
Chest, 106 (1994), pp. 904-912
[31]
JA Butland, J Pang, BR Gross, AA Woodcock, DM Geddes.
Two, six-, and 12-minute walking test in respiratory disease.
Br Med J, 284 (1982), pp. 1607-1608
[32]
MC Gallego, J Samaniego, J Alonso, A Sánchez, S Carrizo, JM Marín.
Disnea en la EPOC: relación de la escala MRC con la disnea inducida en las pruebas de marcha y de ejercicio cardiopulmonar máximo.
Arch Bronconeumol, 38 (2002), pp. 112-116
[33]
KJ Killian, E Summers, NL Jones, EJM Campbell.
Dyspnea and leg effort during incremental cycle ergometry.
Am Rev Respir Dis, 145 (1992), pp. 1339-1345
[34]
V Sobradillo, M Miratvilles, R Gabriel, C Jiménez-Ruiz, C Villasante, JF Masa, et al.
Geographical variations in prevalence and underdiagnosis of COPD. Results of the IBERPOC multicentre epidemiological study.
Chest, 118 (2000), pp. 981-989

This study was funded by grants from RED RESPIRA (RTIC G03/11), the Spanish Health Research Fund (FIS), and Instituto de Salud Carlos III-FEDER.

Copyright © 2008. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?